Skip to Content
Merck
CN
All Photos(1)

Key Documents

Safety Information

19-0480

Sigma-Aldrich

Magnesium sulfate heptahydrate

JIS special grade, ≥99.5%

Synonym(s):

Epsom salts

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
MgSO4 · 7H2O
CAS Number:
Molecular Weight:
246.47
EC Number:
MDL number:
UNSPSC Code:
12352302
PubChem Substance ID:
Assay:
≥99.5%
grade:
JIS special grade
form:
fine crystals

grade

JIS special grade

vapor density

<0.01 (vs air)

vapor pressure

<0.1 mmHg ( 20 °C)

Assay

≥99.5%

form

fine crystals

availability

available only in Japan

pH

5.0-8.0 (50 g/L)

SMILES string

O.O.O.O.O.O.O.[Mg++].[O-]S([O-])(=O)=O

InChI

1S/Mg.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2

InChI key

WRUGWIBCXHJTDG-UHFFFAOYSA-L

Looking for similar products? Visit Product Comparison Guide

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ran D Goldman et al.
Pediatrics, 132(6), e1634-e1641 (2013-11-28)
Vaso-occlusive episodes (VOEs) are the most common complication of sickle cell disease in children. Treatment with magnesium seems to improve cellular hydration and may result in reduced vaso-occlusion. This study aimed to determine if intravenous (IV) magnesium sulfate (MgSO4) reduces
Feng Gao et al.
The Journal of surgical research, 184(2), 944-950 (2013-05-01)
Magnesium sulfate has been used as an anticonvulsant in severe preeclamptic or eclamptic women prior to surgical trauma, but its effects on neuroinflammation is not well defined. In the present study, we investigated the neuroprotective effects of magnesium sulfate in
E S Bain et al.
BJOG : an international journal of obstetrics and gynaecology, 121(5), 595-603 (2014-01-07)
To evaluate a slower (compared with a standard) infusion rate of the loading dose of magnesium sulphate for preterm fetal neuroprotection as a strategy to reduce maternal adverse effects. Randomised controlled trial. South Australian maternity hospital. Fifty-one women at <30
Karen J Gibbins et al.
Obstetrics and gynecology, 121(2 Pt 1), 235-240 (2013-01-25)
Clinical trials support the efficacy and safety of magnesium sulfate for cerebral palsy prevention. We evaluated the implementation of a clinical protocol for the use of magnesium for cerebral palsy prevention in our large women's hospital, focusing on uptake, indications
D H Salinger et al.
BJOG : an international journal of obstetrics and gynaecology, 120(7), 894-900 (2013-03-28)
To compare magnesium sulphate concentrations achieved by intramuscular and intravenous regimens used for the prevention of eclampsia. Low-resource obstetric hospitals in Nagpur and Vellore, India. Pregnant women at risk for eclampsia due to hypertensive disease. A pharmacokinetic study was performed

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service